You may remember the D.C. Circuit case Matt Zorn and I are working on from this prior post. If not, here's the Preliminary Statement from our Amended Petition:

You can check out the complete filing and appendix here and here.

We got exciting news today: A special panel of the D.C. Circuit has ordered DEA to respond to our petition. Check it out:

According to the D.C. Circuit's Handbook of Practice and Internal Procedures, that's a big deal because it means that a special panel of the Court "finds" that our petition is not "without merit":

It's also a big deal because SRI's petition is all about DEA's unexplained refusal to act on SRI's application to manufacture cannabis for clinical research. As the petition explains, members of Congress from both sides of the aisle, the media, veterans’ organizations, scientists, and many others have been seeking answers from DEA regarding its longstanding delay to act on these applications for years. Now, because of this order, DEA must finally provide those answers in a court filing available for public inspection within the next 30 days.

CADC Orders DEA to Respond to Scottsdale Research Institute, LLC's Petition for Writ of Mandamus
Share this